Work

Prevalence of Extended-Spectrum β-Lactamase-Producing Uropathogens Among Pregnant Women at Okelele Primary Health Care Centre, Ilorin, Kwara State, Nigeria

Year: 2026
Type: article
Study design: Observational Study
Abstract: Background: Extended-spectrum β-lactamase (ESBL)-producing uropathogens constitute an escalating antimicrobial resistance threat among pregnant women, in whom undetected asymptomatic bacteriuria may precipitate pyelonephritis, preterm labour, and low birthweight. However, diagnostic deficits and empirical prescribing in primary care impede proper surveillance and management. Methodology: A descriptive cross-sectional investigation was conducted between April and June 2026 among 109 asymptomatic pregnant women attending Okelele Primary Health Care Centre, Ilorin, Kwara State, Nigeria. Clean-catch midstream urine samples were cultured on cysteine lactose electrolyte-deficient (CLED) and MacConkey agar via a serial tenfold dilution pour- plate technique. Isolates were characterised by Gram staining and standard biochemical assays. Antimicrobial susceptibility was evaluated using the Kirby–Bauer disc diffusion assay, while ESBL production was phenotypically confirmed using the Double- Disc Synergy Test (DDST) according to Clinical and Laboratory Standards Institute (CLSI) guidelines. Demographic and categorical associations were evaluated using Pearson’s chi-square test. Results: Significant bacteriuria (≥105 CFU/mL) was detected in 36 (33.0%) of the 109 participants. Four bacterial species within the order Enterobacterales were isolated: Escherichia coli (16; 44.4%), Klebsiella pneumoniae (9; 25.0%), Enterobacter cloacae (7; 19.4%), and Hafnia alvei (4; 11 .1%). Phenotypic DDST confirmed five ESBL-producing strains (13.9% of recovered isolates), representing an overall population prevalence of 4.6% among screened women. These comprised three E. coli isolates (18.8% of E. coli strains), one K. pneumoniae (11 .1%), and one E. cloacae (14.3%); no H. alvei produced ESBLs. All 36 isolates (100%) were completely resistant to co-amoxiclav (Augmentin), cefuroxime, cefotaxime, and ceftazidime. In contrast, 100% in vitro susceptibility was observed for meropenem, ciprofloxacin, and levofloxacin. Nitrofurantoin susceptibility was 69.4%. Significant bacteriuria was not significantly associated with maternal age (χ² = 1 .285, df = 3, p = 0.733) or religious affiliation (χ² = 0.965, df = 1 , p = 0.326). Conclusion: Significant bacteriuria and multi-drug-resistant ESBL-producing uropathogens circulate among pregnant women at the primary healthcare tier. Strengthening routine urine culture, antimicrobial susceptibility testing, confirmatory ESBL screening, and antenatal antimicrobial stewardship is urgently warranted to guide targeted clinical care.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7225880107
FWCI:
Cites:
Cited by:
Related to: 10